These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria. Hall AP, Doberstyn EB, Karnchanachetanee C, Samransamruajkit S, Laixuthai B, Pearlman EJ, Lampe RM, Miller CF, Phintuyothin P. Br Med J; 1977 Jun 25; 1(6077):1626-8. PubMed ID: 326337 [Abstract] [Full Text] [Related]
9. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria. Ekue JM, Phiri DE, Sheth UK, Mukunyandela M. Bull World Health Organ; 1987 Jun 25; 65(3):369-73. PubMed ID: 3311440 [Abstract] [Full Text] [Related]
10. [Plasmodium falciparum drug resistance and sulfadoxine-pyrimethamine in Africa]. Randriamanjaka JR, Le Bras J, Charmot G, Coulaud JP. Bull Soc Pathol Exot Filiales; 1989 Jun 25; 82(3):381-4. PubMed ID: 2670291 [Abstract] [Full Text] [Related]
11. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria. Salako LA, Aderounmu AF, Laoye JO, Makinde JM, Adio RA. Ann Trop Med Parasitol; 1988 Aug 25; 82(4):325-30. PubMed ID: 3075441 [Abstract] [Full Text] [Related]